The seventh of the trials involving Risperdal is currently underway in the Court of Common Pleas in Philadelphia, Pennsylvania. Cases involving the drug have been ongoing for quite some time and many are still being filed.
According to a representative for www.risperdal-settlement.com, this current trial will be followed by many more. "Unless the company settles out of court, we should expect to see tons of these trials over the next few years."
The company in question is pharmaceutical giant Johnson & Johnson, which manufactures Risperdal. The drug is an atypical antipsychotic that was initially approved to treat schizophrenia as well as other psychiatric disorders. The drug was approved for use in children in 2006, although it has been marketed since the mid 1990's. Many of the more than 5,000 lawsuits pending involving Risperdal involve men who were given the medication as a child, before it was approved for such use in 2006.
The drug allegedly causes gynecomastia in men and boys. This is a condition that causes enlargement of the glands in the breast. The case currently being tried involves a plaintiff who states that he developed female like breasts after being prescribed the drug in 2002 to treat symptoms associated with Asperger's syndrome. The plaintiff was eight years old in 2002, a full four years before the drug was approved for use with children.
"We're seeing many cases just like this," states the representative for Risperdal-settlement.com. "These are cases in which this drug was given to small children before it was even approved to be given to them, and the consequences of those actions are astounding."
Johnson & Johnson recently reported that they have received nearly 20,000 product liability claims that state plaintiffs had endured injuries and complications after taking Risperdal. A total of six trials involving Risperdal have concluded so far in Pennsylvania with many more currently set to go to trial. The representative for Risperdal-settlement.com urges those who have taken this drug and experienced these side effects to reach out to a representative and inquire about filing a claim. More on the topic can be seen on the organization's official website.
Thank You Digital Journal and Drug-Lawsuits.org
also from Digital Journal
Risperdal Lawsuit Filings May End In Settlement
And from Forbes
Philadelphia Flooded With New Risperdal Lawsuits; Trials Split But Include Massive Verdict